SEC Form 4 · accession 0001246360-18-001143
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
Mar 14, 2018
Accepted (ET)
Mar 16, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2018 | M | 36,273 | $18.59 | A | 809,685 | D | |
| Common Stock | Mar 14, 2018 | F | 28,039 | $24.05 | D | 781,646 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.59 | Mar 14, 2018 | M | 36,273 | D | Jun 27, 2011 | May 26, 2018 | Common Stock | 36,273 | 0 | D |